Sunday, 7 September 2025

MRCOG tutorial Monday 8th. September 2025

 

Contact me

Website  

8 September 2025.                         Role-players: 1. Nikita John, Shaima Abozeid.

                                                         Role-players: 2. Charlotte Plant, Ewa Ciolak.

35

Role-play 1.

36

Role-play 2.

37

Viva. Apgar score

38

EMQ. Hepatitis E

39

EMQ. Peutz-Jeghers syndrome

 

This is similar to the cancelled programme on Monday, but I’ll change the role-plays as I don’t want you to have time to prepare before the tutorial – it is best that we simulate the exam.                                        

35.               Role-play 1. Candidate’s instructions will be e-mailed shortly before the tutorial.

36.               Role-play 2. Candidate’s instructions will be e-mailed shortly before the tutorial.

37.               Viva.             Topic will be revealed during the tutorial.

38.               Hepatitis E.                    

Question 1.        What is the most common cause of acute viral hepatitis in the UK?

A

hepatitis A virus

B

hepatitis B virus

C

hepatitis C virus

D

hepatitis D virus

E

hepatitis E virus

F

herpes simplex virus

G

HIV

Question 2.        Which, if any, of the following are correct about HEV.

A

it is a DNA virus

B

it belongs to the genus Hippieviridae

C

it belongs to the genus Hepeviridae

D

it belongs to the genus Hoppieviridae

E

there are six main genotypes

F

genotype 3 is the one of greatest importance in the UK

G

the main reservoir of genotype 3 is intensively-reared chickens

H

the main reservoir of genotype 3 is domestic cats

I

a vaccine exists but is only licensed in Russia

J

none of the above

Question 3.        Which, if any, of the following statements about HEV and pregnancy are true?

A

pregnant women are more susceptible to HEV infection

B

pregnant women are more likely to develop serious disease that the non-pregnant

C

the main risk is neonatal death due to vertical transmission

D

the main risk is maternal death

E

the risk of maternal death is highest with infection in the 1st. trimester

F

rates of preterm birth have been reported

G

rates of stillbirth have been reported

39.               Peutz-Jeghers syndrome.

Abbreviations.

PJS:       Peutz-Jeghers syndrome.

Scenario 1.    Which, if any, of the following are characteristics of PJS?

A

buccal pigmentation

B

gastro-intestinal hamartomas

C

perianal pigmentation

D

increased risk of breast cancer

E

increased risk of cervical adenoma malignum

F

increased risk of colo-rectal cancer

G

increased risk of endometrial cancer

H

increased risk of ovarian cancer

I

increased risk of pancreatic cancer

J

increased risk of prostate cancer

K

increased risk of stomach cancer

Scenario 2.    What is the approximate prevalence of PJS?

A

< 1 in 1,000

B

1 in 1,000 to 1 in 10,000

C

1 in 10,000 to 1 in 100,000

D

1 in 25,000 to 1 in 100,000

E

1 in 25,000 to 1 in 200,000

F

1 in 25,000 to 1 in 300,000

G

1 in 300,000 to 1 in 500,000

H

< 1 in 500,000

Scenario 3.    What is the mode of inheritance in PJS?

A

autosomal dominant

B

autosomal recessive

C

X-linked dominant

D

X-linked recessive

E

Y-linked dominant

F

Y-linked recessive

G

triplet repeat

Scenario 4.    Which, if any, of the following statements are true of PJS?

A

PJS only occurs in families with other affected members

B

PJS mainly occurs in families with other affected members

C

PJS may arise de-novo in families with no other affected members

D

PJS may arise de-novo in families with other affected members

E

PJS does not arise de-novo in families with no other affected members

Scenario 5.    What is the approximate lifetime risk of developing cancer in PJS?

A

10%

B

20%

C

30%

D

40%

E

50%

F

60%

G

70%

H

80%

I

90%

J

>90%

Scenario 6.    What is the relevance of STK11 to PJS?

A

It is part of the postcode of the Peutz-Jeghers Society

B

It is the name of the gene most commonly associated with PJS

C

It is the Ornithological Society’s code for the Orkney Skua

D

Somatic mutations have been found in cervical cancer

E

None of the above

 


Tuesday, 26 August 2025

MRCOG tutorial 28th. August 2025

Contact me

Website  

21 August 2025.                                       Role-players: 1.

                                                                    Role-players: 2.

27

Role-play.

28

Role-play.

29

EMQ. Hepatitis B

30

SBA. Kisspeptin

                                                                                          

27.     Role-play 1. Candidate’s instructions will be e-mailed shortly before the tutorial.

28.     Role-play 1. Candidate’s instructions will be e-mailed shortly before the tutorial.

 

29.      Topic. Hepatitis B and pregnancy.

Abbreviations.

GDM:    gestational diabetes mellitus.

HBeAg: hepatitis B e antigen     

HBsAg:  hepatitis B surface antigen

HBcAb: antibody to hepatitis B core antigen

HBsAb: antibody to hepatitis B surface antigen

HBIG:    hepatitis B immunoglobulin

Question 1.        Is screening for HBV in pregnancy recommended in the UK?

Question 2.        An asymptomatic primigravida books at 10 weeks. Her partner had an acute HBV

infection 4 months ago. What results on routine blood testing would indicate that she has an acute HBV infection?

Question 3.        An asymptomatic primigravida books at 10 weeks. Her partner had an acute HBV

infection 4 months ago. What results on routine blood testing would indicate that she is immune to the HBV as a result of infection?

Question 4.        An asymptomatic primigravida books at 10 weeks. Her partner had an acute HBV

infection 4 months ago. What results on routine blood testing would indicate that she is immune to the HBV as a result of HBV vaccine?

Question 5.        An asymptomatic primigravida books at 10 weeks. Her partner had an acute HBV

infection 9 months ago. What results on routine blood testing would show that she is a chronic carrier of HBV infection, assuming that she became infected early in the partner’s illness?

Question 6.        Testing shows that he is positive for HBsAg, positive for HBcAb but negative for IgM

 HBcAb. What does this mean in relation to his HBV status?

Question 7.        Testing shows that he is negative for HBsAg, positive for HBcAb and positive for

HBsAb. What does this mean in relation to his HBV status?

Question 8.        How common is chronic HBV carrier status in UK pregnant women?

Question 9.        What is the risk of death from chronic HBV carrier status?

Question 10.    A primigravid woman at 8 weeks gestation is found to be non-immune to HBV. She has

recently married and her husband is a chronic carrier. What should be done to protect her from infection?

Question 11.    A woman is a known carrier of HBV. What is the risk of vertical transmission in the first

trimester?

Question 12.    What is the risk of the neonate who has been infected by vertical transmission

becoming a carrier without treatment?

Question 13.    Should antiviral maternal therapy in the 3rd. trimester be considered for women with

HBeAg or high viral load?

Question 14.    How effective is hepatitis B prophylaxis for the neonate in preventing chronic carrier

status as a result of vertical transmission?

Question 15.    What alternative treatment could be used if HBIG is not available?

Question 16.    Can a woman who is a chronic HBV carrier breastfeed safely?

Question 17.    Hepatitis B infection is the most dangerous of the viral hepatitis infections in

pregnancy.

Question 18.    A pregnant woman who is not immune to HBV has a partner who is a chronic carrier.

Can HBV vaccine be administered safely in pregnancy?

Question 19.    How long can HBV survive outside the body?

Question 20.    A pregnant woman who is not immune has a partner with acute hepatitis due to HBV.

He cuts his hand and bleeds onto the kitchen table. How should she clean the surface to ensure that she gets rid of the virus?

Question 21.    Is it true that the presence of HBeAg in maternal blood is a particular risk factor for

vertical transmission? Not really a scenario, but never mind!

Question 22.    What does 5 log10 copies /mL mean?

A

> 10 copies / mL

B

> 100 copies / mL

C

> 1,000 copies / mL

D

> 10,000 copies / mL

E

> 100,000 copies / mL

F

this has scared me witless and I am going straight home to complain to my Mum

Question 23.    Which, if any, of the following statements are true about amniocentesis and CVS and

the risk of vertical transmission if the mother is HbsAg+ve?

A

they are contraindicated

B

they should be done with cover with HBIG

C

they should be done with cover with a drug that is  effective for HBV and safe in pregnancy.

D

none of the above

Question 24.    Which, if any, of the following statements are true about treatment in the third

trimester to reduce the risk of vertical transmission?

A

women who are HbsAg+ve should be offered testing for HBV DNA levels in the 3rd. trimester

B

there is no effective treatment for HBV in the 3rd. trimester

C

the risks of treatment for HBV in the 3rd. trimester outweigh the benefits

D

drug treatment for HBV in the 3rd. trimester adds nothing beneficial to the normal use of HBIG + HB vaccination of the neonate

E

none of the above.

Question 25.    Which, if any, of the following drugs is recommended for use in the third trimester to

 reduce the risk of vertical transmission?

A

acyclovir 

B

lamivudine

C

telbivudine

D

tenofovir

Question 26.    Does elective Cs before labour and with the membranes intact reduce the vertical

transmission rate?

Question 27.    Which hepatitis virus normally produces a mild illness, but represents a major risk to

pregnant women, with a mortality rate of up to 5%?

Question 28.    A pregnant woman has a history of viral hepatitis and informs the midwife at booking

that she is a carrier and that she has a significant risk of cirrhosis and has been advised not to drink alcohol. Which is the most likely hepatitis virus?

Question 29.    Which hepatitis virus is an absolute contraindication to breastfeeding after

appropriate treatment of the infected mother and prophylaxis for the baby?

Question 30.    Which hepatitis virus is linked to an increased risk of obstetric cholestasis?

Question 31.    Which, if any, of the following statements is true in relation to HepB and the risk of

GDM?

A

the risk is about the same

B

the relative risk is about 0.1.

C

the relative risk is about 0.2.

D

the relative risk is about 0.5.

E

the relative risk is about 1.2.

F

the relative risk is about 1.5.

G

the relative risk is about 2.0

H

the relative risk is about 3.0

I

the risk is unknown

 

30.     Kisspeptin.

DYNOP:   dynorphin

KSP:         kisspeptin.

NKB:        neurokinin B

Question 1.        Pick the best statement.

A

is a pheromone released by the salivary glands during passionate embraces which ­ syntocinon secretion and sense of pleasure

B

is a digestive enzyme released by the salivary glands during passionate embrace

C

is a digestive enzyme found in human carnivores but not vegetarians

D

is thought necessary for trophoblastic invasion and low levels have been linked to miscarriage, recurrent miscarriage and risk of PET

E

is named after “Kiss me quick” chocolate

F

does not exist and this question is a very poor joke by someone who should know better

Question 2.        Which, if any of the following are true.

A

KSP is a KNDy neuropeptide secreted in the hypothalamus

B

KSP stimulates GnRH neurones

C

KSP stimulates FSH production > LH production

D

KSP stimulates FSH production < LH production

E

KSP stimulates FSH production and LH production equally

F

KSP is a key factor in puberty

G

KSP is a key factor in normal reproductive physiology

H

¯ KSP is pathognomonic for Kallmann’s syndrome.

I

dynorphin stimulates GnRH neurones

J

neurokinin B stimulates GnRH neurones